NumbSkin Pain Relief Cream Recalled by SeeNext Venture Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)
NumbSkin pain relief cream with lidocaine
Date of Recall
2020-03-18CPSC Release Number
20-724Manufactured In
CanadaUnits
About 8,000Importer
SeeNext Venture Ltd., of Blaine, Wash.Sold By
Online at Amazon.com from October 2019 through February 2020 for about $25.Problem/Hazard
The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving cream contains lidocaine, posing a risk of poisoning to young children if they put it on their skin or ingest it.Injuries/Incidents
None reported.Description
This recall involves NumbSkin pain relief cream with 5% lidocaine. The topical anesthetic cream was sold in 30 grams in a white with blue tube. NumbSkin is printed on the tube. Lot 9238 and a date code of 10/2019 through 09/2020 in a MM/YYYY format is embossed on the tub's thin end. Batch number 9238 is printed on the product packaging.
Remedy
ReplaceConsumer Contact
SeeNext Venture toll-free at 844-700-6862 from 9 a.m. to 6 p.m. PT Monday through Saturday, email at [email protected] or online at www.numbskin.com and click on Recall at the home page for more information.Recall Comments
Be the first to add a comment!